WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011145035) NOVEL 3,5-DISUBSTITUED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF PROTEIN KINASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/145035    International Application No.:    PCT/IB2011/052120
Publication Date: 24.11.2011 International Filing Date: 13.05.2011
IPC:
C07D 471/04 (2006.01), A61K 31/437 (2006.01), A61K 31/4709 (2006.01), A61P 35/00 (2006.01)
Applicants: INCOZEN THERAPEUTICS PVT. LTD. [IN/IN]; "Spectrum" Discovery Zone SP Biotech Park, Phase I Shameerpet Hyderabad 500 078 (IN) (For All Designated States Except US).
RHIZEN PHARMACEUTICALS SA [CH/CH]; Fritz Courvoisier 40 CH-2300 La Chaux de Fonds (CH) (For All Designated States Except US).
MUTHUPPALANIAPPAN, Meyyappan [IN/IN]; (IN) (For US Only).
VISWANADHA, Srikant [IN/IN]; (IN) (For US Only).
BABU, Govindarajulu [IN/IN]; (IN) (For US Only).
VAKKALANKA, Swaroop K. V. S. [IN/CH]; (CH) (For US Only)
Inventors: MUTHUPPALANIAPPAN, Meyyappan; (IN).
VISWANADHA, Srikant; (IN).
BABU, Govindarajulu; (IN).
VAKKALANKA, Swaroop K. V. S.; (CH)
Priority Data:
1377/CHE/2010 17.05.2010 IN
Title (EN) NOVEL 3,5-DISUBSTITUED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF PROTEIN KINASES
(FR) NOUVEAU COMPOSÉS DE 3,5-DISUBSTITUÉS-3H-IMIDAZO[4,5-B]PYRIDINE ET 3,5- DISUBSTITUÉS -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE UTILISÉS COMME MODULATEURS DES PROTÉINES KINASES
Abstract: front page image
(EN)The present invention provides, inter alia, compounds of formula ΙΑ,ΙΙΑ and III as protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.
(FR)L'invention concerne, notamment, des composés représentés par les formules ΙΑ,ΙΙΑ et III utilisés comme modulateurs de la protéine kinase, leurs procédés de préparation, des compositions pharmaceutiques les contenant et des méthodes de traitement, de prévention et/ou d'amélioration des maladies ou des troubles à médiation kinase.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)